PFND

Healthcare Biotechnology

Pathfinder Cell Therapy, Inc.

$0.00

-0.00 -0.00% today

Price History

Not enough data

Key Stats

Market Cap

66,716.086

Avg Volume

52W High

$0.00

52W Low

$0.00

Div. Yield

0.0%

Valuation

P/B Ratio

-0.01

EV/EBITDA

-7.01

Margins

Gross Margin 0.0%

Operating Margin 0.0%

Net Margin 0.0%

EBITDA Margin 0.0%

Growth & Returns

Return on Assets

(888.8%)

Liquidity & Leverage

Current Ratio

0.00

Quick Ratio

0.00

Total Cash

4,000

Total Debt

5.41M

About

Pathfinder Cell Therapy, Inc., a development stage regenerative medicine company, focuses on developing novel cell-derived and related therapies for the treatment of various diseases and medical conditions characterized by organ-specific cell damage. It identifies diabetes, renal disease, myocardial infarction, peripheral vascular disease, and other diseases as potential indications for therapies based on its technology. The company was founded in 2008 and is headquartered in Cambridge, Massachusetts.